HCMSG - Hepatitis C Mentor & Support Group, Inc.

  • Home
  • OUR SERVICES
    • Our Services Map
    • THE CIRCLE Registration
    • The Circle Model >
      • How does the Circle Model Work
      • Sites
      • Group and Facilitator Guide
      • Circle Model Data Form
    • TRAINING >
      • HepCTraining
  • RESOURCES
  • Blog
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
    • Support Us
    • Contact Us
  • Home
  • OUR SERVICES
    • Our Services Map
    • THE CIRCLE Registration
    • The Circle Model >
      • How does the Circle Model Work
      • Sites
      • Group and Facilitator Guide
      • Circle Model Data Form
    • TRAINING >
      • HepCTraining
  • RESOURCES
  • Blog
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
    • Support Us
    • Contact Us

AMA urges Administration to save lives by moving naloxone from behind the counter

2/18/2022

0 Comments

 
Feb. 18, 2022: National Advocacy Update- AMA

The AMA asked the Biden administration to take additional steps to remove the prescription status of naloxone—the overdose-reversing drug—to make it more available over the counter.    
“As the overdose epidemic has worsened, given the FDA’s clear guidance there is no moral, medical, or safety-related reason for these life-saving overdose reversal agents to remain locked under prescription regulations,” the AMA wrote (PDF) the Office of National Drug Control Policy (ONDCP).    
If not for naloxone, tens of thousands of additional Americans likely would have died from overdoses. The AMA greatly appreciates ONDCP has made increasing access to naloxone a high priority and recommended steps that would make it more widely available to harm-reduction organizations and individuals regardless of their insurance status. The letter notes that naloxone manufacturers are dragging their feet on making it more available over the counter.

TO CONTINUE: ​https://www.ama-assn.org/health-care-advocacy/advocacy-update/feb-18-2022-national-advocacy-update?utm_source=SFMC&utm_medium=email&utm_term=2182022&utm_content=22-9997_Advocacy_Update_021822&utm_campaign=Advocacy_Email_Newsletter_AdvocacyUpdate&utm_uid=15829237&utm_effort=#ama-urges-administration-to-save-lives-by-moving-naloxone-from-behind-the-counter

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021

    Categories

    All

    RSS Feed

Privacy Policy
Disclaimer:  Information given by Hepatitis C Mentor and Support Group is not a substitute for advice given by your physician or health care provider.  We do not endorse any doctor, hospital, medical group, or treatment.